Literature DB >> 23049206

Novel insight into mechanisms of cholestatic liver injury.

Benjamin L Woolbright1, Hartmut Jaeschke.   

Abstract

Cholestasis results in a buildup of bile acids in serum and in hepatocytes. Early studies into the mechanisms of cholestatic liver injury strongly implicated bile acid-induced apoptosis as the major cause of hepatocellular injury. Recent work has focused both on the role of bile acids in cell signaling as well as the role of sterile inflammation in the pathophysiology. Advances in modern analytical methodology have allowed for more accurate measuring of bile acid concentrations in serum, liver, and bile to very low levels of detection. Interestingly, toxic bile acid levels are seemingly far lower than previously hypothesized. The initial hypothesis has been based largely upon the exposure of μmol/L concentrations of toxic bile acids and bile salts to primary hepatocytes in cell culture, the possibility that in vivo bile acid concentrations may be far lower than the observed in vitro toxicity has far reaching implications in the mechanism of injury. This review will focus on both how different bile acids and different bile acid concentrations can affect hepatocytes during cholestasis, and additionally provide insight into how these data support recent hypotheses that cholestatic liver injury may not occur through direct bile acid-induced apoptosis, but may involve largely inflammatory cell-mediated liver cell necrosis.

Entities:  

Keywords:  Apoptosis; Bile acids; Bile duct ligation; Cholestasis; Innate immunity; Necrosis; Neutrophils

Mesh:

Substances:

Year:  2012        PMID: 23049206      PMCID: PMC3460324          DOI: 10.3748/wjg.v18.i36.4985

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  103 in total

Review 1.  Anti-fibrogenic strategies and the regression of fibrosis.

Authors:  Tatiana Kisseleva; David A Brenner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-04       Impact factor: 3.043

2.  Eccentric contractions decrease glucose transporter transcription rate, mRNA, and protein in skeletal muscle.

Authors:  S Kristiansen; J Jones; A Handberg; G L Dohm; E A Richter
Journal:  Am J Physiol       Date:  1997-05

3.  Cytoprotection by fructose and other ketohexoses during bile salt-induced apoptosis of hepatocytes.

Authors:  I M Zeid; S F Bronk; P J Fesmier; G J Gores
Journal:  Hepatology       Date:  1997-01       Impact factor: 17.425

4.  Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation.

Authors:  C M Rodrigues; X Ma; C Linehan-Stieers; G Fan; B T Kren; C J Steer
Journal:  Cell Death Differ       Date:  1999-09       Impact factor: 15.828

Review 5.  Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury.

Authors:  Hartmut Jaeschke; John J Lemasters
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

6.  Induction of the mitochondrial permeability transition as a mechanism of liver injury during cholestasis: a potential role for mitochondrial proteases.

Authors:  G J Gores; H Miyoshi; R Botla; H I Aguilar; S F Bronk
Journal:  Biochim Biophys Acta       Date:  1998-08-10

7.  Tauroursodeoxycholic acid reduces bile acid-induced apoptosis by modulation of AP-1.

Authors:  Thomas Pusl; Timo Vennegeerts; Ralf Wimmer; Gerald U Denk; Ulrich Beuers; Christian Rust
Journal:  Biochem Biophys Res Commun       Date:  2007-12-27       Impact factor: 3.575

8.  Effects of hypochlorous acid and chloramines on vascular resistance, cell integrity, and biliary glutathione disulfide in the perfused rat liver: modulation by glutathione.

Authors:  M Bilzer; B H Lauterburg
Journal:  J Hepatol       Date:  1991-07       Impact factor: 25.083

9.  Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection.

Authors:  R Botla; J R Spivey; H Aguilar; S F Bronk; G J Gores
Journal:  J Pharmacol Exp Ther       Date:  1995-02       Impact factor: 4.030

10.  Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting.

Authors:  Jocelyn Trottier; Andrzej Białek; Patrick Caron; Robert J Straka; Piotr Milkiewicz; Olivier Barbier
Journal:  PLoS One       Date:  2011-07-08       Impact factor: 3.240

View more
  72 in total

1.  Aldehyde dehydrogenase-2 activation by Alda-1 decreases necrosis and fibrosis after bile duct ligation in mice.

Authors:  Hereward J Wimborne; Kenji Takemoto; Patrick M Woster; Don C Rockey; John J Lemasters; Zhi Zhong
Journal:  Free Radic Biol Med       Date:  2019-09-23       Impact factor: 7.376

2.  Bile Acid-Induced Toxicity in HepaRG Cells Recapitulates the Response in Primary Human Hepatocytes.

Authors:  Benjamin L Woolbright; Mitchell R McGill; Huimin Yan; Hartmut Jaeschke
Journal:  Basic Clin Pharmacol Toxicol       Date:  2015-08-13       Impact factor: 4.080

3.  Toxicogenomic module associations with pathogenesis: a network-based approach to understanding drug toxicity.

Authors:  J J Sutherland; Y W Webster; J A Willy; G H Searfoss; K M Goldstein; A R Irizarry; D G Hall; J L Stevens
Journal:  Pharmacogenomics J       Date:  2017-04-25       Impact factor: 3.550

Review 4.  Sterile inflammation in acute liver injury: myth or mystery?

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015       Impact factor: 3.869

5.  Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis.

Authors:  Benjamin L Woolbright; Kenneth Dorko; Daniel J Antoine; Joanna I Clarke; Parviz Gholami; Feng Li; Sean C Kumer; Timothy M Schmitt; Jameson Forster; Fang Fan; Rosalind E Jenkins; B Kevin Park; Bruno Hagenbuch; Mojtaba Olyaee; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2015-01-28       Impact factor: 4.219

Review 6.  Therapeutic targets for cholestatic liver injury.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Expert Opin Ther Targets       Date:  2015-10-19       Impact factor: 6.902

Review 7.  Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology.

Authors:  Tirthadipa Pradhan-Sundd; Satdarshan Pal Monga
Journal:  Gene Expr       Date:  2019-01-15

8.  Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glands.

Authors:  Hayato Nakagawa; Nobumi Suzuki; Yoshihiro Hirata; Yohko Hikiba; Yoku Hayakawa; Hiroto Kinoshita; Sozaburo Ihara; Koji Uchino; Yuji Nishikawa; Hideaki Ijichi; Motoyuki Otsuka; Junichi Arita; Yoshihiro Sakamoto; Kiyoshi Hasegawa; Norihiro Kokudo; Keisuke Tateishi; Kazuhiko Koike
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

9.  Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice.

Authors:  Benjamin L Woolbright; Daniel J Antoine; Rosalind E Jenkins; Mary Lynn Bajt; B Kevin Park; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2013-10-03       Impact factor: 4.219

Review 10.  Role of matrix metalloproteinases in cholestasis and hepatic ischemia/reperfusion injury: A review.

Authors:  Giuseppina Palladini; Andrea Ferrigno; Plinio Richelmi; Stefano Perlini; Mariapia Vairetti
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.